Helomics

77 employees

Helomics provides comprehensive tumor profiling utilizing proprietary tissue-based live cell and fixed cell products and services.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Health Diagnostics

Health Care

Biomarker Testing

Personalized Cancer Care

Therapeutics

Gynecologic Cancers

Cancer Therapeutics

Gene Signatures

Precision Medicine

CSRA Testing

Date founded

1995

Funding rounds raised

Total raised

$60M

from 25 investors over 25 rounds

Helomics raised undisclosed on December 19, 2017

Investors: Skyline Medical

Helomics raised $60M on November 13, 2014

Investors: HealthCare Royalty Partners

Helomics raised $33M on June 11, 2010

Investors: TVM Life Science Management Inc, ACM Remodeling, Draper Triangle Ventures, Longitude Capital and Birchmere Ventures

Helomics raised $43M on November 11, 2008

Investors: Birchmere Ventures, Draper Triangle Ventures, ACM Remodeling, Longitude Capital and Techno Venture Management

Helomics raised $20M on March 10, 2006

Investors: TVM Life Science Management Inc, ACM Remodeling, Draper Triangle Ventures and Birchmere Ventures

Helomics raised $15M on September 9, 2003

Investors: ACM Remodeling, Draper Triangle Ventures, Techno Venture Management and Birchmere Ventures

Helomics raised $18M on November 13, 2001

Investors: TVM Life Science Management Inc, Birchmere Ventures and Draper Triangle Ventures

Helomics raised $9M on March 28, 2001

Investors: Draper Triangle Ventures and Birchmere Ventures